Home › Neuroendocrine Tumors › California › San Francisco
Neuroendocrine Tumors clinical trials in San Francisco, CA
5 studies for Neuroendocrine Tumors are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
RecruitingPhase 1
- UCSF Benioff Children's Hospital, San Francisco
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- UCSF Medical Center-Mission Bay, San Francisco
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, San Francisco
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
RecruitingPhase 2
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, San Francisco
Neuroendocrine Tumors trials in other cities
- Philadelphia, PA11 studies
- Washington, DC11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- St. Louis, MO7 studies
- Chicago, IL7 studies
- Columbus, OH7 studies
- Detroit, MI7 studies
- Cleveland, OH7 studies
- Salt Lake City, UT7 studies
- Dallas, TX6 studies
- Charlottesville, VA6 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer22 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.